Advantages and pitfalls of the glycated hemoglobin A1c measurement in acute coronary syndrome: Start simple, evolve to more sophisticated
Citation
Karakurt, M.Y., Açar, B., Özeke, O., Özbay, M. B., Özen, Y., Karanfil, M., Unal, S., Cay, S., Maden, O., Aras, D., Topaloğlu, S.B., Aydoğdu, S., Gölbaşı, Z. (2018). Advantages and pitfalls of the glycated hemoglobin A1c measurement in acute coronary syndrome: Start simple, evolve to more sophisticated. Angiology, 70(2), 182-184.Abstract
We would like to thank Cetin et al1 for their interest in our work titled, “Association of Prediabetes With Higher Coronary Atherosclerotic Burden Among Patients With First Diagnosed Acute Coronary Syndrome”2 about the association of prediabetes with higher coronary atherosclerotic burden among patients with first diagnosed acute coronary syndrome (ACS). Cetin et al reported some concerns about the categorization of the study population using only glycated hemoglobin (HbA1c) level might be misleading and especially overdiagnosing prediabetic population.
